Associations of non alcoholic fatty liver with the metabolic syndrome and serum carotenoids

Journal of Preventive Medicine and Public Health

Volumn 41, Issue 1, 2008, Pages 39-44

  Park, Sun Kyun ^a   Lee, Hyun Jung ^b   Lee, Duk Hee ^a   Lee, Sung Kook ^a   Chun, Byung Yeol ^b   Kim, Sung Ae ^a   Lee, Hye Sung ^b   Son, Hyo Kyung ^a   Kim, Sung Hi ^c  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University   (South Korea)

^c Catholic University of Daegu   (South Korea)

Author keywords

Carotenoids; Fatty liver; Insulin resistance; Metabolic syndrome X; Obesity; Oxidative stress

Indexed keywords

CAROTENOID;

ADULT; ARTICLE; BLOOD; FATTY LIVER; FEMALE; HEALTH BEHAVIOR; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS;

ADULT; CAROTENOIDS; FATTY LIVER; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS;

EID: 41649103718     PISSN: 19758375     EISSN: None     Source Type: Journal    
DOI: 10.3961/jpmph.2008.41.1.39     Document Type: Article

References (24)

1. Falck-Ytter Y, Younossi ZM, Marchesini G,McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndrome. Semin Liver Dis 2001; 21(1): 17-26.
2. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122(6): 1649-1657.
3. Hoyumpa AM Jr, Greene HL, Dunn GD, Schenker S. Fatty Liver: Biochemical and clinical considerations. Am J Dig Dis 1975; 20(12): 1142-1170.
4. Isselbacher KJ, Podosky DK. Infiltrative and metabolic disease affecting the liver. In: Braunwald E, Isselbacher KJ, Paterdorf RG, editors. Harrison's Principle of Internal Medicine. New York: McGraw-Hill; 1991. p. 1352-1355.
5. Sung NE. Obesity and dietary habit. J Korean Med Assoc 1989; 32(5): 502-506. (Korean)
6. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonal-dehyde and related aldehydes. Free Radic Biol Med 1991; 11(1): 81-128.
7. Saibara T, Ono M, Onishi S. NASH and metabolic syndrome. Nippon Rinsho 2006; 64(6): 1165-1167.
8. Marchesini G, Babini M. Nonalcoholic fatty liver disease and the metabolic syndrome. Minerva Cardioangiol 2006; 54(2): 229-239.
9. Hwang SW, Kim MJ. Association of Nonalcoholic fatty liver disease with metabolic syndrome over 65 years elderly. J Korean Geriatr Soc 2004; 8(2): 82-88. (Korean)
10. Moon KW, Leem JK, Bae SS, Lee KM, Kim SH, Chae HB, et al. The prevalence of metabolic syndrome in patients with nonalcoholic fatty liver disease. Korean J Hepatol 2004; 10(3): 197-206. (Korean)
11. Park KS, Jang BK, Kwon KM, Chung WJ, Cho KB, et al. Antioxidant status in nonalcoholic steatohepatitis. Korean J Hepatol 2005; 11(2): 135-143. (Korean)
12. Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004; 99(8): 1497-1502.
13. Letteron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 1996; 24(2): 200-208.
14. Bieri JG, Tolliver TJ, Catignani GL. Simultaneous determination of T-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am J Clin Nutr 1979; 32(10): 2143-2149.
15. Inoue S, Zimmet P, Caterson I, Chen C, Ikeda Y, Khalid DA, et al. The Asia-pacific perspective: Redefining obesity and its treatment. Health Communication Australia Pty Limited: 2000. [cited 2007 Aug 16]; Available from: URL:http://www.diabetes.com.au/pdf/obesity-report.pdf.
16. Song JH, Kim EK, Shin C, Kim SS, Kim JK, Jung MH, et al. Meatbolic syndrome and its alternative definition for prevalent diabetes mellitus in Korean population: The Ansan study. Korean J Lipidol 2003; 13(1): 9-12. (Korean)
17. Earl S, Wayne H, William H. Prevalence of the metabolic syndrome among US adults: Findings from the third national health and nutrition examination survey. JAMA 2002; 287(3): 356-359.
18. Lombardi B. Considerations on the pathogenesis of fatty liver. Lab Invest 1966; 15(1): 1-20.
19. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114(12): 1752-1761.
20. Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006; 70(11): 1437-1442.
21. Bahcecioglu IH, Yalniz M, Ilhan N, Ataseven H, Ozercan H. Levels of serum vitamin A, alpha-tocopherol and malondialdehyde in patients with non-alcoholic steatohepatitis: Relationship with histopathologic severity. Int J Clin Pract 2005; 59(3): 318-323.
22. Chae HB, Kim MS, Park SM, Sung RH, Youn SJ. Nonalcoholic fatty liver disease: A spectrum of clinical and sonographical severity. Chungbuk Med J 2000; 10(1): 43-51. (Korean)
23. Ohm SH, Yoo BC, Kim SJ, Lee CU, Pai KT, Kim SC, et al. A cross-sectional study on the risk factors related to fatty liver. J Prev Med Public Health 1993; 26(2): 179-191. (Korean)
24. Ahn JE, Ham JO, Hwang KY, Kim JJ, Lee BK, Nam TS, et al. A cross-sectional study on prevalence rate and contributing factors of fatty liver diagnosed by ultrasonography. J Prev Med Public Health 1991; 24(2): 195-210. (Korean)